06.17.14
The U.S. Food and Drug Administration has given Toshiba America Medical Systems Inc. clearance to market its myocardial perfusion software, which will be available on the company's Aquilion One and Aquilion One Vision computed tomography (CT) scanners. The technology is used to help clinicians visualize myocardial ischemia and assess whether the patient should undergo coronary blockage revascularization.
The myocardial perfusion software on Toshiba’s 320-detector-row CTs shows blood flow and anatomy within the coronary arteries to help determine the viability of the heart muscle. This enables clinicians to make faster and more accurate decisions on whether to undergo revascularization of coronary blockages. Toshiba’s CT Myocardial Perfusion puts patient experience first with shorter exam times and significantly lower radiation exposure, when compared with traditional coronary artery disease evaluation methods, the company claims.
“Heart disease has remained the number one cause of death in the United States, according to the Centers for Disease Control and Prevention, and new CT technology is helping diagnose cardiac disease sooner,” said Satrajit Misra, senior director of the CT Business Unit at Toshiba. “The Aquilion One’s ability to capture the entire heart in a single rotation and its Myocardial Perfusion capability allow clinicians to make better decisions on treatment. Additionally, Toshiba’s simplified dose reduction technology, AIDR 3-D, ensures that CT dose and safety is not a choice hospitals or patients should have to make.”
Headquartered in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR (magnetic resonance), ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States.
Toshiba Medical Systems Corporation provides medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems is a wholly owned subsidiary of Toshiba, a manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba was founded in 1875, and today operates a global network of more than 590 consolidated companies, with 206,000 employees worldwide and annual sales surpassing 5.8 trillion yen ($61 billion).
The myocardial perfusion software on Toshiba’s 320-detector-row CTs shows blood flow and anatomy within the coronary arteries to help determine the viability of the heart muscle. This enables clinicians to make faster and more accurate decisions on whether to undergo revascularization of coronary blockages. Toshiba’s CT Myocardial Perfusion puts patient experience first with shorter exam times and significantly lower radiation exposure, when compared with traditional coronary artery disease evaluation methods, the company claims.
“Heart disease has remained the number one cause of death in the United States, according to the Centers for Disease Control and Prevention, and new CT technology is helping diagnose cardiac disease sooner,” said Satrajit Misra, senior director of the CT Business Unit at Toshiba. “The Aquilion One’s ability to capture the entire heart in a single rotation and its Myocardial Perfusion capability allow clinicians to make better decisions on treatment. Additionally, Toshiba’s simplified dose reduction technology, AIDR 3-D, ensures that CT dose and safety is not a choice hospitals or patients should have to make.”
Headquartered in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR (magnetic resonance), ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States.
Toshiba Medical Systems Corporation provides medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems is a wholly owned subsidiary of Toshiba, a manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba was founded in 1875, and today operates a global network of more than 590 consolidated companies, with 206,000 employees worldwide and annual sales surpassing 5.8 trillion yen ($61 billion).